Intelligent Bio Solutions Inc. Common Stock (INBS) Stock Price
INBSStock
$2.36−83.11%52W
Market Cap$7.12M
P/E—
PEG Ratio—
Div yield—
Beta4.32
INBS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-59.49%
Price vs S&P 500 (4W)53.79%
VGM Score65.70
INBS Earnings Surprise History
Q1 26-1.80est. —
Q2 26-0.90est. -1.58
INBS Analyst Recommendations
Feb 2025
Mar 2025
Jul 2026
Aug 2026
4.29
4.29
4.29
4.29
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
INBSIntelligent Bio Solutions Inc. Common Stock | A | A | D | $2.36 |
| SYKStryker Corporation | C | B | C | $330.59 |
| MMM3M Company | C | D | B | $179.37 |
| BSXBoston Scientific Corp. | C | B | D | $49.86 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.78 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.64 |
| RMDResMed Inc. | C | B | C | $236.59 |
| DXCMDexCom, Inc. | D | B | B | $89.16 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $348.48 |
| SOLVSolventum Corporation | C | C | B | $91.61 |
| BAXBaxter International Inc. | B | D | B | $26.29 |
About Intelligent Bio Solutions Inc. Common Stock
Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive diagnostic tests, including a biosensor platform for chronic disease monitoring and a portable drug screening solution that analyzes fingerprint sweat. The company's products offer real-time, hygienic alternatives to traditional diagnostic and substance screening methods. It operates across four geographic segments—United Kingdom, Asia Pacific, Americas, and Rest of World—with the United Kingdom representing its largest revenue source.